BPG is committed to discovery and dissemination of knowledge
Prospective Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Sep 21, 2026; 32(35): 118677
Published online Sep 21, 2026. doi: 10.3748/wjg.118677
Table 1 Basal characteristics of 101 participants with inflammatory bowel disease, n (%)/median (interquartile ranges)
Variable

Female60 (59.4)
Age in years49 (35-59)
Residency
Mexico City45 (44.6)
State of Mexico17 (16.8)
State of Hidalgo10 (9.9)
Education level
Illiterate1 (1.0)
Basic131 (30.7)
Intermediate222 (21.8)
Higher347 (46.5)
Smoking index0 (0-0.75)
Previous CDI9/98 (9.2)
Previous hospitalization49 (8.9)
Previous healthcare utilization423 (22.8)
Previous antibiotic use434/99 (34.3)
Previous statin use412 (11.9)
Proton pump inhibitor use439 (38.6)
Previous bowel surgery31 (30.7)
Age at diagnosis of IBD in years35 (26-50)
Disease duration at inclusion in years9 (4-16)
Type of IBD
Ulcerative colitis78 (77.2)
Crohn’s disease22 (21.8)
Indeterminate colitis1 (1.0)
Extent of ulcerative colitis, n = 78
Proctitis11 (10.9)
Left-sided colitis19 (18.8)
Pancolitis48 (47.5)
Days without IBD activity before follow-up936 (238-1088)
Severity of last flare-up
Mild23/60 (38.3)
Moderate32/60 (53.3)
Severe (uncomplicated)5/60 (8.4)
Treatment at baseline (not mutually exclusive)
Sulfasalazine or mesalamine73/99 (73.7)
Corticosteroids34/99 (34.3)
Azathioprine32/99 (32.3)
Infliximab3/99 (3.0)
Methotrexate2/99 (2.0)
Laboratory parameters at baseline
Hb in g/L145 (127-153)
Platelet count as × 103/μL275 (232-344)
Leukocyte count as × 103/μL6.7 (5.2-8.5)
Lymphocyte count as × 103/μL1.7 (1.2-2.7)
Serum creatinine in mg/L8 (6-9)
Blood urea nitrogen in mg/L144 (116-177)
C-reactive protein in mg/L4 (3-9)
Fecal calprotectin in pg/g278 (77.5-660)
Erythrocyte sedimentation rate in mm/hour8 (4-15)
Baseline CDC frequency14/101 (13.9)
Baseline CDI frequency2/101 (2.0)


Write to the Help Desk